APA (7th ed.) Citation

XA, L., T, C., RR, C., JS, P., MH, T., PT, K., & S, S. (2023). A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial. Addiction (Abingdon, England), 118(7), 1320. https://doi.org/10.1111/add.16163

Chicago Style (17th ed.) Citation

XA, Levander, Carmody T, Cook RR, Potter JS, Trivedi MH, Korthuis PT, and Shoptaw S. "A Gender-based Secondary Analysis of the ADAPT-2 Combination Naltrexone and Bupropion Treatment for Methamphetamine Use Disorder Trial." Addiction (Abingdon, England) 118, no. 7 (2023): 1320. https://doi.org/10.1111/add.16163.

MLA (9th ed.) Citation

XA, Levander, et al. "A Gender-based Secondary Analysis of the ADAPT-2 Combination Naltrexone and Bupropion Treatment for Methamphetamine Use Disorder Trial." Addiction (Abingdon, England), vol. 118, no. 7, 2023, p. 1320, https://doi.org/10.1111/add.16163.